HWM
ORGO icon

HighMark Wealth Management’s Organogenesis Holdings ORGO Stock Holding History

HighMark Wealth Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.7K Sell
11,829
-291,200
-96% -$712K 0.01% 218
2026
Q1 		$718K Hold
303,029
– – 0.29% 43
2025
Q4 		$1.57M Buy
303,029
+10,000
+3% +$48.5K 0.64% 23
2025
Q3 		$1.24M Hold
293,029
– – 0.54% 25
2025
Q2 		$1.07M Buy
+293,029
New +$1.09M 0.52% 24

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

HighMark Wealth Management's ORGO Position: Q2 2026 in Review

HighMark Wealth Management reduced its Organogenesis Holdings (ORGO) stake by 96% in Q2 2026, selling an estimated $712K and leaving 11,829 shares worth $28.7K. The position accounts for 0.01% of the portfolio, ranked #218.

HighMark Wealth Management first reported a position in ORGO in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.57M in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • HighMark Wealth Management held 11,829 shares of Organogenesis Holdings worth $28.7K as of Q2 2026.
  • HighMark Wealth Management sold 291,200 Organogenesis Holdings shares in Q2 2026, an estimated $712K.
  • Organogenesis Holdings made up 0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #218 holding.
  • HighMark Wealth Management first reported a position in Organogenesis Holdings in Q2 2025 and has held it in 5 quarters since.
  • HighMark Wealth Management's Organogenesis Holdings position peaked at $1.57M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.